Urovant Sciences Ltd EV/EBIT
What is the EV/EBIT of Urovant Sciences Ltd?
The EV/EBIT of Urovant Sciences Ltd is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Urovant Sciences Ltd
Companies with ev/ebit similar to Urovant Sciences Ltd
- Singular Health Ltd has EV/EBIT of N/A
- Biome Australia Ltd has EV/EBIT of N/A
- Shine Minerals has EV/EBIT of N/A
- Premier has EV/EBIT of N/A
- Excelsior Mining has EV/EBIT of N/A
- Cutera Inc has EV/EBIT of N/A
- Urovant Sciences Ltd has EV/EBIT of N/A
- Danlaw Technologies India has EV/EBIT of N/A
- Pinehurst Capital I has EV/EBIT of N/A
- Amforge Industries has EV/EBIT of N/A
- True Leaf Brands has EV/EBIT of N/A
- OBITX has EV/EBIT of N/A
- Clear Blue Technologies International has EV/EBIT of N/A